0001415889-23-011318.txt : 20230719 0001415889-23-011318.hdr.sgml : 20230719 20230719161002 ACCESSION NUMBER: 0001415889-23-011318 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230718 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaBarre Michael J. CENTRAL INDEX KEY: 0001507174 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 231096808 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 12390 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-07192023_080758.xml X0508 4 2023-07-18 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001507174 LaBarre Michael J. C/O HALOZYME THERAPEUTICS, INC. 12390 EL CAMINO REAL SAN DIEGO CA 92130 false true false false SVP, CHIEF TECHNICAL OFFICER 1 Common Stock 2023-07-18 4 M 0 10000 18.41 A 151911 D Common Stock 2023-07-18 4 S 0 10000 40.43 D 141911 D Common Stock 2023-07-18 4 M 0 7175 13.81 A 149086 D Common Stock 2023-07-18 4 M 0 2825 8.11 A 151911 D Option to Purchase Common Stock 18.41 2023-07-18 4 M 0 10000 0 D 2028-02-14 Common Stock 10000 7505 D Option to Purchase Common Stock 13.81 2023-07-18 4 M 0 7175 0 D 2025-02-04 Common Stock 7175 26825 D Option to Purchase Common Stock 8.11 2023-07-18 4 M 0 2825 0 D 2026-02-03 Common Stock 2825 75627 D The option exercise and sale reported on this Form 4 were effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person. Represents a weighted average sales price per share. These shares were sold at prices ranging from $40.10 to $40.84. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents an acquisition of 7,175 shares by the Reporting Person pursuant to a cash exercise and hold transaction. Represents an acquisition of 2,825 shares by the Reporting Person pursuant to a cash exercise and hold transaction. This option was granted on February 14, 2018 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. This option was granted on February 4, 2015 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. This option was granted on February 3, 2016 and vested one-fourth on the first anniversary of such date and then 1/48th monthly thereafter. /s/ James R. Oehler, Attorney-in-Fact 2023-07-19